Previous 10 | Next 10 |
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today provided preliminary financial results for the third quarter ended September 30, 2023, as well as recent business updates. Some Company highlights:...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Cutera Inc. (CUTR) is expected to report $-0.79 for Q3 2023
2023-11-07 17:35:53 ET More on Cutera Cutera: Consider Both Financial Outlook And New CEO Appointment (Rating Upgrade) Cutera shares rise 18% as CEO, CFO buy $346K in stock Seeking Alpha’s Quant Rating on Cutera Historical earnings data for Cutera ...
Cutera, Inc. (Nasdaq: CUTR ) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2023 after the market close on Wednesday, November 8, 2023. The C...
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that on October 3, 2023 the Compensation Committee of Cutera’s Board of Directors approved the grant of inducement awards to Brent...
Hauser Brings Over 20 Years of Aesthetics Industry Experience in Markets Across the Globe Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Brent Hause...
2023-09-27 16:00:00 ET Summary While we may have been bullish about INMD's eventual reversal to its historical valuations, it appears that our bullish investment thesis has been temporarily invalidated. This is despite the FQ2'23 double beats, raised FY2023 guidance, and optimisti...
2023-09-25 00:09:00 ET Summary For the week, the S&P 500 was down 2.9%. The best performer last week was Volatility, as investors were willing to pay higher premiums to hedge their downside risk. Transportation and Healthcare stocks held up the best last week, while defens...
2023-09-19 10:55:02 ET Summary Cutera's FY 2023 revenue guidance suggests that the company's top line is expected to contract on both a YoY and HoH (Half-on-Half) basis in the second half of this year. On the flip side, a new CEO was appointed in August, and his recent share purch...
News, Short Squeeze, Breakout and More Instantly...
CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that it will report financial results for the second quarter ended June 30, 2024, after the market closes on Thursday, August 8, 2024. The Company’s management will host a conference...
New insights reveal the profound impact of acne and the growing interest in modern treatments Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announces the release of important new acne survey data as part of June’s Acne Awareness Month. Th...
Experienced Healthcare Executive Brings Extensive Financial and Operational Expertise to Cutera Board of Directors CUTERA, INC. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, announced today that Jeryl “Jeri” Hilleman will join its Board of Direct...